CD274 and neoplasm: In pre-treatment biopsies, some cell types with potential contributions to immunotherapy outcomes were identified, particularly the cell subtypes associated with T cell clonal proliferation: immunoregulatory dendritic cells (PD-L1+), specialized macrophages (CCR2+ or MMP9+), and tumor cells expressing MHC-I/II were positively correlated with T cell expansion.